scholarly journals The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study

2015 ◽  
Vol 14 (1) ◽  
pp. 10 ◽  
Author(s):  
Sanjoy K Paul ◽  
Kerenaftali Klein ◽  
David Maggs ◽  
Jennie H Best
Keyword(s):  
Type 2 Diabetes ◽  
Observational Study ◽  
Receptor Agonist ◽  
Cardiovascular Outcomes ◽  
Retrospective Observational Study ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1

938-P: The Relationship between Timing of Initiation on a Glucagon-Like Peptide-1 Receptor Agonist and HbA1c among Patients with Type 2 Diabetes

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 938-P
Author(s):  
RALEIGH E. MALIK ◽  
REEMA MODY ◽  
MAUREEN J. LAGE ◽  
KRISTINA BOYE
Keyword(s):  
Type 2 Diabetes ◽  
Receptor Agonist ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1 ◽  
Timing Of Initiation ◽  
The Relationship
Sign in / Sign up

Export Citation Format

Share Document